Matthew Andrews's Stock Ratings

Jefferies Analyst

Matthew Andrews is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/30/2025

Overall Average Return

47.1%

Smart Score

77.4%

Overall Average Return Percentile

94th

Number of Ratings

8
Buy NowGet Alert
11/01/2023TGTXBuy Now
TG Therapeutics
$39.88
Matthew Andrews77%
MaintainsBuyGet Alert
02/06/2019CARABuy Now
Cara Therapeutics
$5.57294.97%
Matthew Andrews77%
→ $264Assumes → BuyGet Alert
11/08/2018ALNABuy Now
Allena Pharmaceuticals
Matthew Andrews77%
→ $22Assumes → BuyGet Alert
09/13/2018CARABuy Now
Cara Therapeutics
$5.57438.6%
Matthew Andrews77%
→ $360Initiates → BuyGet Alert
11/27/2017ALNABuy Now
Allena Pharmaceuticals
Matthew Andrews77%
→ $22Initiates → BuyGet Alert
09/12/2017CTICBuy Now
CTI BioPharma
Matthew Andrews77%
→ $7.5Initiates → BuyGet Alert
04/25/2017TGTXBuy Now
TG Therapeutics
$39.88-42.33%
Matthew Andrews77%
→ $23Initiates → BuyGet Alert
03/21/2017GNMXBuy Now
Aevi Genomic Medicine
Matthew Andrews77%
$10 → $2.5DowngradeBuy → HoldGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free